Philogen SpA (MIL:PHIL) Risk Assessment


MIL:PHIL Philogen SpA MIL:PHIL
61 GF Score
Price €25.55
GF Value €229.14
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Philogen SpA Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Philogen SpA is: High Risk: Sensitive to economic or industry trends.

Philogen SpA  (MIL:PHIL) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Philogen SpA Risk Assessment Related Terms

MIL:PHIL vs VRTX, REGN, ALNY: Risk Assessment Comparison

For the Biotechnology subindustry, Philogen SpA's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Philogen SpA Risk Assessment vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Philogen SpA's Risk Assessment falls into.


MIL:PHIL
61GF Score
Philogen SpA MIL:PHIL
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Philogen SpA (MIL:PHIL) Overvalued in 2026?

Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued. The current stock price of €25.55 is trading 88.8% below its estimated GF Value™ of €229.14. GuruFocus considers Philogen SpA to be Possible Value Trap.

Key valuation signals for MIL:PHIL:

  • Risk Assessment:
  • GF Value™: €229.14 vs. price of €25.55 (88.8% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the MIL:PHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Philogen SpA Business Description

Other Exchanges 78Q:Germany
Address Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
61GF Score

Get the complete analysis for MIL:PHIL

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€25.55
Price
€229.14
GF Value